Clinical Laserthermia Systems AB Class B (LS60) Ratios
Clinical Laserthermia Systems AB Class B Ratios
DE:LS60's free cash flow for Q2 2026 was $-9.16M. For the 2026 fiscal year, DE:LS60's free cash flow was decreased by $-4.43M and operating cash flow was $-4.73M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.91 | 2.99 | 1.94 | 0.58 | 0.93 |
| Quick Ratio | 2.64 | 2.35 | 1.50 | 0.55 | 0.84 |
| Cash Ratio | 2.15 | 1.75 | 1.10 | 0.25 | 0.04 |
| Solvency Ratio | -3.90 | -3.49 | -5.43 | -1.64 | -1.38 |
| Operating Cash Flow Ratio | -3.32 | -4.39 | -4.76 | -1.70 | -1.46 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -2.30 | -381.41 |
| Net Current Asset Value | $ 29.12M | $ 25.53M | $ 12.95M | $ -17.38M | $ -3.13M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.62 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 3.33 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.77 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.10 | 1.14 | 1.26 | 5.37 | 3.06 |
| Debt Service Coverage Ratio | -281.07 | -103.36 | -7.01 | -1.37 | -8.67 |
| Interest Coverage Ratio | -308.57 | -125.30 | -6.76 | -6.15 | -9.47 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.43 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.06 | 3.04 | 96.21 | 23.22 |
| Net Debt to EBITDA | 0.82 | 0.50 | 0.22 | -0.35 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | -165.81% | 55.47% | 36.23% | -44.51% | -161.69% |
| EBIT Margin | -165.81% | -252.50% | -859.59% | -961.92% | -2571.76% |
| EBITDA Margin | -151.03% | -238.28% | -826.86% | -922.83% | -2541.31% |
| Operating Profit Margin | -165.81% | -288.85% | -796.97% | -1075.97% | -2702.98% |
| Pretax Profit Margin | -240.44% | -254.80% | -977.58% | -1136.97% | -2857.06% |
| Net Profit Margin | -237.96% | -253.54% | -964.49% | -1127.31% | -2833.63% |
| Continuous Operations Profit Margin | -240.44% | -254.80% | -977.58% | -1136.97% | -2857.06% |
| Net Income Per EBT | 98.97% | 99.50% | 98.66% | 99.15% | 99.18% |
| EBT Per EBIT | 145.01% | 88.21% | 122.66% | 105.67% | 105.70% |
| Return on Assets (ROA) | -54.40% | -60.62% | -138.23% | -142.73% | -95.32% |
| Return on Equity (ROE) | -59.73% | -69.30% | -174.34% | -766.63% | -291.89% |
| Return on Capital Employed (ROCE) | -43.61% | -82.59% | -150.70% | -857.50% | -285.11% |
| Return on Invested Capital (ROIC) | -43.61% | -82.32% | -149.91% | -173.56% | -121.50% |
| Return on Tangible Assets | -63.83% | -83.97% | -205.41% | -221.91% | -134.93% |
| Earnings Yield | -23.38% | -118.17% | -86.07% | -99.65% | -27.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.58 | 2.47 | 2.08 | 0.75 | 0.35 |
| Payables Turnover | 7.91 | 1.33 | 0.58 | 1.53 | 1.36 |
| Inventory Turnover | 3.66 | 1.03 | 0.86 | 6.05 | 1.41 |
| Fixed Asset Turnover | 1.25 | 3.93 | 2.13 | 3.48 | 1.52 |
| Asset Turnover | 0.23 | 0.24 | 0.14 | 0.13 | 0.03 |
| Working Capital Turnover Ratio | 0.64 | 0.97 | -3.93 | -0.61 | -0.37 |
| Cash Conversion Cycle | 155.43 | 228.92 | -35.57 | 310.32 | 1039.15 |
| Days of Sales Outstanding | 101.88 | 147.93 | 175.64 | 489.15 | 1049.02 |
| Days of Inventory Outstanding | 99.69 | 355.70 | 423.04 | 60.28 | 258.14 |
| Days of Payables Outstanding | 46.13 | 274.71 | 634.25 | 239.12 | 268.02 |
| Operating Cycle | 201.57 | 503.63 | 598.68 | 549.43 | 1307.16 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.28 | -5.13 | -19.78 | -163.29 | -230.10 |
| Free Cash Flow Per Share | -1.39 | -5.35 | -21.42 | -164.58 | -232.03 |
| Dividend Paid and CapEx Coverage Ratio | -11.86 | -22.93 | -12.09 | -125.78 | -119.23 |
| Capital Expenditure Coverage Ratio | -11.86 | -22.93 | -12.09 | -125.78 | -119.23 |
| Operating Cash Flow Coverage Ratio | 0.00 | -252.03 | -146.38 | -2.30 | -241.96 |
| Operating Cash Flow to Sales Ratio | -1.90 | -3.01 | -8.03 | -11.28 | -29.48 |
| Free Cash Flow Yield | -20.23% | -146.20% | -77.61% | -100.48% | -28.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.27 | -0.85 | -1.16 | -1.00 | -3.70 |
| Price-to-Sales (P/S) Ratio | 10.18 | 2.15 | 11.21 | 11.31 | 104.92 |
| Price-to-Book (P/B) Ratio | 2.55 | 0.59 | 2.03 | 7.69 | 10.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.94 | -0.68 | -1.29 | -1.00 | -3.53 |
| Price-to-Operating Cash Flow Ratio | -5.36 | -0.71 | -1.40 | -1.00 | -3.56 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | 0.01 | 0.01 | -0.01 | -0.87 |
| Enterprise Value Multiple | -5.92 | -0.40 | -1.14 | -1.58 | -4.10 |
| Enterprise Value | 156.45M | 18.02M | 77.83M | 91.14M | 234.10M |
| EV to EBITDA | -5.92 | -0.40 | -1.14 | -1.58 | -4.10 |
| EV to Sales | 8.95 | 0.96 | 9.41 | 14.54 | 104.28 |
| EV to Free Cash Flow | -4.35 | -0.31 | -1.08 | -1.28 | -3.51 |
| EV to Operating Cash Flow | -4.71 | -0.32 | -1.17 | -1.29 | -3.54 |
| Tangible Book Value Per Share | 2.13 | 3.98 | 7.34 | -22.64 | 5.53 |
| Shareholders’ Equity Per Share | 2.69 | 6.24 | 13.63 | 21.29 | 75.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Revenue Per Share | 0.68 | 1.71 | 2.46 | 14.48 | 7.81 |
| Net Income Per Share | -1.61 | -4.33 | -23.75 | -163.22 | -221.20 |
| Tax Burden | 0.99 | 1.00 | 0.99 | 0.99 | 0.99 |
| Interest Burden | 1.45 | 1.01 | 1.14 | 1.18 | 1.11 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.26 | 0.34 | 0.94 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 18.99 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 1.19 | 0.83 | 1.00 | 1.04 |
Currency in SEK